{
    "clinical_study": {
        "@rank": "65633", 
        "acronym": "New Drink", 
        "arm_group": [
            {
                "arm_group_label": "flavanol rich drink intervention", 
                "arm_group_type": "Active Comparator", 
                "description": "flavanol rich drink"
            }, 
            {
                "arm_group_label": "methylxanthine rich drink intervention", 
                "arm_group_type": "Active Comparator", 
                "description": "methylxanthine rich drink"
            }, 
            {
                "arm_group_label": "flavanol + methylxanthine rich drink intervention", 
                "arm_group_type": "Active Comparator", 
                "description": "flavanol + methylxanthine rich drink"
            }
        ], 
        "brief_summary": {
            "textblock": "Epidemiological studies suggest that certain foods rich in flavanols, including cocoa\n      products, red wine, and tea, are associated with decreased cardiovascular mortality and\n      morbidity. Dietary interventional studies have corroborated this finding and showed that\n      flavanols can acutely and after sustained ingestion improve surrogate markers of\n      cardiovascular risk including endothelial function. Endothelial dysfunction is the key event\n      in the development and progression of cardiovascular disease. Aging is the major\n      non-modifiable cardiovascular risk factor associated with progressive decline in endothelial\n      function, vascular stiffening and increase in blood pressure.\n\n      However, in addition to flavanols, other potentially bioactive compounds are present in\n      cocoa, in particular methylxanthines. Little is known about the vascular effects of cocoa\n      methylxanthines, i.e. mainly theobromine, in particular when consumed together with\n      flavanols in cocoa products. The aim of the study is to characterize the nutrient-nutrient\n      interaction between cocoa flavanols and cocoa methylxanthines."
        }, 
        "brief_title": "Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cardiovascular Diseases", 
        "condition_browse": {
            "mesh_term": "Cardiovascular Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy male subjects\n\n          -  >18 years\n\n        Exclusion Criteria:\n\n          -  acute inflammation\n\n          -  cardiac arrhythmia\n\n          -  renal failure\n\n          -  heart failure (NYHA II-IV)\n\n          -  diabetes mellitus\n\n          -  CRP > 1 mg/dl\n\n          -  malignant disease"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02149238", 
            "org_study_id": "New Drink"
        }, 
        "intervention": [
            {
                "arm_group_label": "flavanol rich drink intervention", 
                "intervention_name": "flavanol", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "methylxanthine rich drink intervention", 
                "intervention_name": "methylxanthine", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "flavanol + methylxanthine rich drink intervention", 
                "intervention_name": "flavanol + methylxanthine", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "flavanols", 
            "cardiovascular effects", 
            "nutrition-nutrition interaction"
        ], 
        "lastchanged_date": "May 26, 2014", 
        "location": {
            "contact": {
                "email": "christian.heiss@med.uni-duesseldorf.de", 
                "last_name": "Christian Heiss, MD", 
                "phone": "00492118118800"
            }, 
            "contact_backup": {
                "email": "rabea.wagstaff@med.uni-duesseldorf.de", 
                "last_name": "Rabea Wagstaff, B.Sc., M.A.", 
                "phone": "00492118118800"
            }, 
            "facility": {
                "address": {
                    "city": "Duesseldorf", 
                    "country": "Germany", 
                    "zip": "40225"
                }, 
                "name": "Division of Cardiology, Pulmonology and Vascular Medicine"
            }, 
            "investigator": [
                {
                    "last_name": "Christian Heiss, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Roberto Sansone, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "3", 
        "official_title": "Acute Study to Investigate the Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects", 
        "overall_contact": {
            "email": "Christian.Heiss@med.uni-duesseldorf.de", 
            "last_name": "Christian Heiss, MD", 
            "phone": "00492118118800"
        }, 
        "overall_contact_backup": {
            "email": "rabea.wagstaff@med.uni-duesseldorf.de", 
            "last_name": "Rabea Wagstaff, B.Sc., M.A.", 
            "phone": "00492118118800"
        }, 
        "overall_official": [
            {
                "affiliation": "Division of Cardiology, Pulmonology and Vascular Medicine", 
                "last_name": "Christian Heiss, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Cardiology, Pulmonology and Vascular Medicine", 
                "last_name": "Malte Kelm, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Flow mediated dilatation (FMD)", 
                "measure": "Endothelial function", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }, 
            {
                "description": "Measured by HPLC", 
                "measure": "Plasma flavanol metabolites", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02149238"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Heinrich-Heine University, Duesseldorf", 
            "investigator_full_name": "Klinik f\u00fcr Kardiologie, Pneumologie und Angiologie", 
            "investigator_title": "Klinik f\u00fcr Kardiologie, Pneumologie und Angiologie", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Measured by SphygmoCor", 
                "measure": "Pulse wave velocity", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }, 
            {
                "description": "automatical measurements", 
                "measure": "Ambulatory blood pressure", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }, 
            {
                "measure": "Circulation angiogenetic cells", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }
        ], 
        "source": "Heinrich-Heine University, Duesseldorf", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Heinrich-Heine University, Duesseldorf", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}